SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Little Gorilla who wrote (20409)4/13/1999 10:11:00 AM
From: John M. Gelnieau  Read Replies (2) | Respond to of 23519
 
This PR really moved the price!



To: Little Gorilla who wrote (20409)4/13/1999 10:43:00 AM
From: Mkilloran  Read Replies (3) | Respond to of 23519
 
LG...Todays Press Release documenting the Safety study of VVUS MUSE
is great data for the sales partners Astra/Zeneca and Janssen to use to sell MUSE over Viagra to this group of patients that may be at greater risk using Viagra.



To: Little Gorilla who wrote (20409)4/13/1999 1:08:00 PM
From: Mkilloran  Respond to of 23519
 
LG...How many cardiac patients use Nitro???
Answer = millions.......( I belive about 5 million in the USA)

How many patients that use Nitro can use Viagra???
Answer = ZERO.......

How many cardiac patients that use Nitro are impotent???
Answer = many........

How many of the above should try Muse???
answer = many.........


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News